Related Experiment Video
Updated: Apr 12, 2026
Models of Bone Metastasis
Published on: September 4, 2012
New therapeutic targets for cancer bone metastasis
Jing Y Krzeszinski1, Yihong Wan2
1Department of Pharmacology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Abstract:
Bone metastases are dejected consequences of many types of tumors including breast, prostate, lung, kidney, and thyroid cancers. This complicated process begins with the successful tumor cell epithelial-mesenchymal transition, escape from the original site, and penetration into the circulation. The homing of tumor cells to the bone depends on both tumor-intrinsic traits and various molecules supplied by the bone metastatic niche. The colonization and growth of cancer cells in the osseous environment, which awaken their dormancy to form micro- and macro-metastasis, involve an intricate interaction between the circulating tumor cells and local bone cells including osteoclasts, osteoblasts, adipocytes, and macrophages. We discuss the most recent advances in the identification of new molecules and novel mechanisms during each step of bone metastasis that may serve as promising therapeutic targets.
Insights
Bone metastases occur when cancer cells spread to bones, involving complex interactions between tumor cells and bone cells. Understanding these mechanisms offers new therapeutic targets for various cancers.
Area of Science:
- Oncology
- Cancer Biology
- Bone Metastasis Research
Background:
- Bone metastases are a common and severe complication of many cancers, including breast, prostate, and lung cancer.
- The process involves tumor cell detachment, circulation, and colonization within the bone microenvironment.
- Interactions between tumor cells and local bone cells (osteoclasts, osteoblasts, adipocytes, macrophages) are critical for metastasis progression.
Purpose of the Study:
- To review recent advances in understanding the molecular mechanisms of bone metastasis.
- To identify novel therapeutic targets at each stage of bone metastasis.
Main Methods:
- Literature review of recent scientific advances.
- Analysis of molecular and cellular interactions in bone metastasis.
Main Results:
- Bone metastasis involves epithelial-mesenchymal transition, circulation, and homing to bone.
- The bone metastatic niche provides essential factors for tumor cell survival and growth.
- Complex crosstalk between tumor cells and bone cells drives dormancy and outgrowth.
Conclusions:
- Identifying new molecules and mechanisms offers promising therapeutic strategies for bone metastasis.
- Targeting specific steps in the bone metastasis cascade could improve patient outcomes.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:57Targeted Cancer Therapies
01:27Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:26Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...